Network Insights Methodology Get Access

Marty Makary

PERSON Government / FDA - Drug and Device Regulation Momentum 6.9ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. CRITICALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Source Concentration

Marty Makary, physician and public health commentator, departed FDA leadership in May 2026 amid organizational restructuring at HHS. His exit followed disputes over FDA regulatory interpretation and internal governance.

Recent departure from FDA leadership role within HHS
0.16
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
6.9
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
32
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Connected Entities
FDA Dr. White House Robert F. Kennedy Jr. HHS WASHINGTON PlocamiumAI United States President Reuters Americans Washington, D.C. Meta Platforms Senate CMS
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-28 2026-05-29 32 0 Degree Mentions
Signal Decomposition
Attention Cascade
0.236
Narrative Drift
0.000
Spectral Shift
0.000
Sentiment-Momentum Divergence
0.000
Source Concentration
0.310
Peer Comparison
Not yet ranked. Sector-relative scoring requires at least four entities in the same BICS sector with PSI history; this entity does not yet meet the threshold or sits in a sector with insufficient peers.
Network Analysis
32 Degree Centrality
Ego Network (top connections)
FDA (weight 118.0)Dr. (weight 29.0)White House (weight 19.0)Robert F. Kennedy Jr. (weight 17.0)HHS (weight 17.0)WASHINGTON (weight 14.0)PlocamiumAI (weight 7.0)United States (weight 7.0) FDADr.White HouseRobert F. Kenned…HHSWASHINGTONPlocamiumAIUnited States Marty Makary (degree 32) Marty Makary
Centrality History
2026-05-28 2026-05-29 32 0 Degree Mentions
EntityWeight StatusFirst Seen
FDA 118 NEW
Dr. 29 NEW
White House 19 NEW
Robert F. Kennedy Jr. 17 NEW
HHS 17 NEW
WASHINGTON 14 NEW
PlocamiumAI 7 NEW
United States 7 NEW
President 5 NEW
Reuters 5 NEW
Americans 5 NEW
Washington, D.C. 3 NEW
Meta Platforms 3 NEW
Senate 3 NEW
CMS 3 NEW
CNN 3 NEW
JD Vance 2 NEW
REUTERS 2 NEW
Vice President 2 NEW
AOL 2 NEW
New York Times 2 NEW
Canada 2 NEW
WSJ 2 NEW
RFK Jr. 2 NEW
Merck 2 NEW
Alphabet 2 NEW
CNBC 2 NEW
CEO 2 NEW
AP 2 NEW
Bloomberg 2 NEW
Article Coverage (20)
DateLaneTitle
2026-05-26 Healthcare Marketing FDA Blocks Weight-Loss Drugs From Compounding Pharmacies as Supply Concerns Mount
2026-05-26 Healthcare Marketing FDA Blocks Weight-Loss Drugs From Compounding Pharmacies as Supply Concerns Mount
2026-05-25 Healthcare Marketing FDA Approves First Non-Antipsychotic Drug For Dementia Agitation, Reshaping Treatment Options
2026-05-15 Healthcare Marketing FDA Blocks Melanoma Drug as Makary's Chaos Erodes Patient Trust in Approvals
2026-05-15 Healthcare Marketing FDA Blocks Melanoma Drug as Makary's Chaos Erodes Patient Trust in Approvals
2026-05-15 Healthcare Marketing Minnesota Health System Secures $205 Million to Avert Collapse
2026-05-15 Healthcare M&A Blackstone, Audax Build Pharmaceutical Consulting Empires to Capitalize on Regulatory Chaos
2026-05-10 Healthcare M&A Daiichi Sankyo Scraps $950 Million ADC Plant as Oncology Buildout Backfires
2026-05-09 Healthcare Marketing Health Systems Face Marketing Crisis as Hospital-At-Home Proves Superior Outcomes Without Facility Walls
2026-05-09 Healthcare Marketing OpenAI Targets Patient Records as Healthcare Revenue Engine Accelerates
2026-05-09 Healthcare Marketing Trump Ousts FDA Commissioner Makary in Regulatory Overhaul Push
2026-05-07 Healthcare Marketing White House Order Pushes FDA to Fast-Track Serious Mental Health Treatments
2026-04-24 Healthcare Marketing FDA Unlocks Gene Therapy For Hearing Loss, Signaling Shift in Rare Disease Treatment
2026-04-22 Healthcare Marketing What Healthcare Marketers Need to Know About Ibogaine's Clinical Promise and Regulatory Path
2026-04-20 Healthcare Marketing FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
2026-04-20 Healthcare Marketing FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
2026-04-20 Healthcare Marketing Trump Signs Executive Order to Loosen Restrictions on Psychedelic Drugs
2026-03-27 Healthcare M&A Mississippi Health System Goes 'all In' on Epic With $115M Investment
2026-03-26 Healthcare Marketing CVS, FTC Reach Proposed Settlement in Insulin Pricing Case
2026-03-26 Healthcare M&A Eli Lilly's Deal Man, Allogene's Off-The-Shelf CAR-T, and Merck's Terns Buy

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-29 ← Intelligence Network